Last-Minute Cancellation Of Advisory Panel Meeting Throws Future of Luveniq Into Doubt

23 Jun 2010

• By The Pink Sheet Daily

"Several outstanding issues" forced FDA to cancel the meeting, the agency said.

More from Archive